Related Experiment Video
Updated: Jun 23, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
The association between Staphylococcus aureus bacteremia and acute myocardial infarction
Vicente F Corrales-Medina1, Omid Fatemi, Jose Serpa
1Michael E. DeBakey VA Medical Center, Houston, Texas 77030, USA. vfmedina@bcm.edu
Abstract:
We evaluated a possible association between S. aureus bacteremia (SAB) and the occurrence of myocardial infarction (MI) in 588 patients using the self-controlled case series method. SAB increased the risk for MI 35-fold in the 2 d after recognition of this infection (IRR = 35.3; CI 16.7-74.7).
Insights
Staphylococcus aureus bacteremia (SAB) significantly elevates the risk of myocardial infarction (MI). Patients faced a 35-fold higher chance of heart attack within two days of SAB diagnosis.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Staphylococcus aureus bacteremia (SAB) is a serious condition.
- Understanding the cardiovascular risks associated with SAB is crucial for patient management.
Purpose of the Study:
- To investigate the association between S. aureus bacteremia and the incidence of myocardial infarction (MI).
Main Methods:
- Utilized a self-controlled case series methodology.
- Analyzed data from 588 patients diagnosed with S. aureus bacteremia.
Main Results:
- SAB was associated with a substantial increase in the risk of myocardial infarction.
- The risk for MI increased 35-fold within the first 2 days following SAB recognition (IRR = 35.3; CI 16.7-74.7).
Conclusions:
- S. aureus bacteremia poses an acute and significant risk for myocardial infarction.
- Prompt recognition and management of SAB are critical to mitigate cardiovascular complications.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Endocarditis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Staphylococcal Skin Infections
